Cargando…
Correction to: Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Autor principal: | Frampton, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183497/ https://www.ncbi.nlm.nih.gov/pubmed/32323221 http://dx.doi.org/10.1007/s40265-020-01316-w |
Ejemplares similares
-
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
por: Frampton, James E.
Publicado: (2020) -
Eculizumab in the treatment of neuromyelitis optica spectrum disorder
por: Nabizadeh, Fardin, et al.
Publicado: (2023) -
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
por: Singh, Pratap, et al.
Publicado: (2021) -
Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
por: Nie, Tina, et al.
Publicado: (2022) -
Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report
por: Chatterton, Sophie, et al.
Publicado: (2022)